S'identifier

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar, it must undergo an additional phase II reaction. This subsequent reaction converts the nonpolar metabolite into a polar conjugate, enhancing its excretability. During hepatic drug oxidation, the oxidized form of P450 initially binds with the parent drug, creating a binary-drug complex. This complex is then reduced by NADPH–P450 reductase. Following this reduction, the complex uses molecular oxygen and another electron to form an "activated oxygen"-P450-substrate complex. The activated oxygen is then transferred to the drug, creating the oxidized drug metabolite. In conclusion, the monooxygenase P450 cycle plays a crucial role in a phase I reaction, oxidizing a parent drug and introducing a hydroxyl group.

Tags
Drug MetabolismPhase I ReactionsBiochemical ProcessCytochrome P450HemoproteinsEndoplasmic ReticulumPolar GroupMetaboliteHepatic Drug OxidationBinary drug ComplexNADPH P450 ReductaseActivated OxygenOxidized Drug MetaboliteMonooxygenase P450 Cycle

Du chapitre 3:

article

Now Playing

3.17 : Drug Metabolism: Phase I Reactions

Pharmacokinetics

2.8K Vues

article

3.1 : Pharmacocinétique : Vue d’ensemble

Pharmacokinetics

4.6K Vues

article

3.2 : Mécanisme d’absorption du médicament : transport membranaire passif

Pharmacokinetics

3.2K Vues

article

3.3 : Mécanisme d’absorption du médicament : transport membranaire médié par le transporteur

Pharmacokinetics

3.1K Vues

article

3.4 : Absorption des médicaments : facteurs affectant l’absorption gastro-intestinale

Pharmacokinetics

3.4K Vues

article

3.5 : Biodisponibilité : Vue d’ensemble

Pharmacokinetics

2.3K Vues

article

3.6 : Facteurs influençant la biodisponibilité : élimination au premier passage

Pharmacokinetics

5.7K Vues

article

3.7 : Bioéquivalence : Vue d’ensemble

Pharmacokinetics

843 Vues

article

3.8 : Effet de premier passage

Pharmacokinetics

4.7K Vues

article

3.9 : Évolution temporelle de l’effet du médicament

Pharmacokinetics

1.8K Vues

article

3.10 : Distribution du médicament : liaison tissulaire

Pharmacokinetics

2.3K Vues

article

3.11 : Barrières physiologiques

Pharmacokinetics

3.1K Vues

article

3.12 : Distribution du médicament : liaison aux protéines plasmatiques

Pharmacokinetics

3.9K Vues

article

3.13 : Modèles à compartiments : Modèle à compartiment unique

Pharmacokinetics

1.9K Vues

article

3.14 : Modèles à compartiments : Modèle à deux compartiments

Pharmacokinetics

4.8K Vues

See More

JoVE Logo

Confidentialité

Conditions d'utilisation

Politiques

Recherche

Enseignement

À PROPOS DE JoVE

Copyright © 2025 MyJoVE Corporation. Tous droits réservés.